These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22021930)

  • 1. Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity.
    Daissormont IT; Christ A; Temmerman L; Sampedro Millares S; Seijkens T; Manca M; Rousch M; Poggi M; Boon L; van der Loos C; Daemen M; Lutgens E; Halvorsen B; Aukrust P; Janssen E; Biessen EA
    Circ Res; 2011 Dec; 109(12):1387-95. PubMed ID: 22021930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.
    Colvin BL; Sumpter TL; Tokita D; Salati J; Mellor AL; Thomson AW
    Hum Immunol; 2009 May; 70(5):313-20. PubMed ID: 19208362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells.
    Yun TJ; Lee JS; Machmach K; Shim D; Choi J; Wi YJ; Jang HS; Jung IH; Kim K; Yoon WK; Miah MA; Li B; Chang J; Bego MG; Pham TN; Loschko J; Fritz JH; Krug AB; Lee SP; Keler T; Guimond JV; Haddad E; Cohen EA; Sirois MG; El-Hamamsy I; Colonna M; Oh GT; Choi JH; Cheong C
    Cell Metab; 2016 May; 23(5):852-66. PubMed ID: 27166946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity.
    Sage AP; Murphy D; Maffia P; Masters LM; Sabir SR; Baker LL; Cambrook H; Finigan AJ; Ait-Oufella H; Grassia G; Harrison JE; Ludewig B; Reith W; Hansson GK; Reizis B; Hugues S; Mallat Z
    Circulation; 2014 Oct; 130(16):1363-73. PubMed ID: 25223984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Autophagy in CD11b
    Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z
    Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
    Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
    Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development.
    Foks AC; Ran IA; Frodermann V; Bot I; van Santbrink PJ; Kuiper J; van Puijvelde GH
    PLoS One; 2013; 8(12):e83134. PubMed ID: 24376654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure.
    Paveglio SA; Allard J; Foster Hodgkins SR; Ather JL; Bevelander M; Campbell JM; Whittaker LeClair LA; McCarthy SM; van der Vliet A; Suratt BT; Boyson JE; Uematsu S; Akira S; Poynter ME
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):11-23. PubMed ID: 20118221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody.
    Asselin-Paturel C; Brizard G; Pin JJ; Brière F; Trinchieri G
    J Immunol; 2003 Dec; 171(12):6466-77. PubMed ID: 14662846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.
    Curran TA; Jalili RB; Farrokhi A; Ghahary A
    Immunobiology; 2014 Jan; 219(1):17-24. PubMed ID: 23891282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo.
    Kim YH; Choi BK; Kang WJ; Kim KH; Kang SW; Mellor AL; Munn DH; Kwon BS
    J Leukoc Biol; 2009 May; 85(5):817-25. PubMed ID: 19218483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.
    Boasso A; Herbeuval JP; Hardy AW; Anderson SA; Dolan MJ; Fuchs D; Shearer GM
    Blood; 2007 Apr; 109(8):3351-9. PubMed ID: 17158233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of indoleamine 2,3-dioxygenase regulates Japanese encephalitis via enhancement of type I/II IFN innate and adaptive T-cell responses.
    Kim SB; Choi JY; Uyangaa E; Patil AM; Hossain FM; Hur J; Park SY; Lee JH; Kim K; Eo SK
    J Neuroinflammation; 2016 Apr; 13(1):79. PubMed ID: 27090635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression.
    Malleret B; Manéglier B; Karlsson I; Lebon P; Nascimbeni M; Perié L; Brochard P; Delache B; Calvo J; Andrieu T; Spreux-Varoquaux O; Hosmalin A; Le Grand R; Vaslin B
    Blood; 2008 Dec; 112(12):4598-608. PubMed ID: 18787223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
    Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
    J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.
    Forteza MJ; Polyzos KA; Baumgartner R; Suur BE; Mussbacher M; Johansson DK; Hermansson A; Hansson GK; Ketelhuth DFJ
    Front Immunol; 2018; 9():950. PubMed ID: 29867939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
    Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
    Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells transfected with indoleamine 2,3-dioxygenase gene suppressed acute rejection of cardiac allograft.
    Li C; Liu T; Zhao N; Zhu L; Wang P; Dai X
    Int Immunopharmacol; 2016 Jul; 36():31-38. PubMed ID: 27107370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.